Axonics secures seven patents in US for implantable sacral neuromodulation technology
Axonics has secured seven patents from the US Patent and Trademark Office for its implantable sacral neuromodulation technology.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Nov 18
Axonics has secured seven patents from the US Patent and Trademark Office for its implantable sacral neuromodulation technology.
16 Nov 18
Dynex Technologies has secured approval from the Chinese Food and Drug Administration (CFDA) to supply its AGILITY instrument…
14 Nov 18
Medical devices maker Lumendi has secured approval from the US Food and Drug Administration (FDA) for its DiLumen…
08 Nov 18
POC diagnostic devices developer PixCell Medical has received the US Food and Drug Administration (FDA) 510(k) clearance for…
08 Nov 18
The US Food and Drug Administration (FDA) has approved claims related to the macro-, micro-, and nano-surface structure…
08 Nov 18
TUV Rheinland OpenSky has helped Insulet’s Omnipod DASH insulin management system to be the first FDA-cleared insulin pump…
06 Nov 18
Teleflex subsidiary NeoTract has received Shonin approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan…
06 Nov 18
Shoulder Innovations has secured 510(k) Clearance from the US Food and Drug Administration (FDA) for its InSet Humeral…
05 Nov 18
The US Food and Drug Administration has approved two devices, which will help detect parathyroid tissue in real-time…
01 Nov 18
Cerus, a biomedical products company focused in the field of blood transfusion safety, has received the US Food…